


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31199065</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>06</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1522-7278</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Jun</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Environmental toxicology</Title>
                <ISOAbbreviation>Environ. Toxicol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>PM<sub>2.5</sub> upregulates rat mesenteric arteries 5-HT<sub>2A</sub> receptor via inflammatory-mediated mitogen-activated protein kinases signaling pathway.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/tox.22810</ELocationID>
            <Abstract>
                <AbstractText>Fine particulate matter (PM<sub>2.5</sub> ) is an important environmental risk factor for cardiovascular diseases. However, little is known about the effects of PM<sub>2.5</sub> on arteries. The present study investigated whether PM<sub>2.5</sub> alters 5-hydroxytryptamine (5-HT) receptor expression and inflammatory mediators on rat mesenteric arteries, and examined the underlying mechanisms. Isolated rat mesenteric arteries segments were cultured with PM<sub>2.5</sub> in the presence or absence of ERK1/2, JNK, and p38 pathway inhibitors. Contractile reactivity was monitored by a sensitive myograph. The expression of 5-HT<sub>2A/1B</sub> receptors and inflammatory mediators were studied by a real-time polymerase chain reaction and/or by immunohistochemistry. The phosphorylation of mitogen-activated protein kinases (MAPK) pathway was detected by Western blot. Compared with the fresh or culture alone groups, 1.0 μg/mL PM<sub>2.5</sub> cultured for 16 hours significantly enhanced contractile response induced by 5-HT and increased 5-HT<sub>2A</sub> receptor mRNA and protein expressions, indicating PM<sub>2.5</sub> upregulates 5-HT<sub>2A</sub> receptor. SB203580 (p38 inhibitor) and U0126 (ERK1/2 inhibitor) significantly decreased PM<sub>2.5</sub> -induced elevated contraction and mRNA and protein expression of 5-HT<sub>2A</sub> receptor. Cultured with PM<sub>2.5</sub> significantly increased the mRNA expression of inflammatory mediators (NOS2, IL-1β, and TNF-α), while SB203580 decreased mRNA expression level of NOS2, IL-1β, and TNF-α. SP600125 (JNK inhibitor) decreased mRNA expression level of TNF-α and IL-1β. After PM<sub>2.5</sub> exposure, the phosphorylation of p38 and ERK1/2 protein were increased. SB203580 and U0126 inhibited the PM<sub>2.5</sub> caused increased phosphorylation protein of p38 and ERK1/2. In conclusion, PM<sub>2.5</sub> induces inflammatory-mediated MAPK pathway in artery which subsequently results in enhanced vascular contraction responding to 5-HT via the upregulated 5-HT<sub>2A</sub> receptors.</AbstractText>
                <CopyrightInformation>© 2019 Wiley Periodicals, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Rong</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Shaanxi Key Laboratory of Ischemic Cardiovascular Disease, Xi'an Medical University, Xi'an, Shaanxi, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Xi'an Medical University, Xi'an, Shaanxi, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cao</LastName>
                    <ForeName>Lei</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shen</LastName>
                    <ForeName>Zhen-Xing</ForeName>
                    <Initials>ZX</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Environmental Science and Engineering, Xi'an Jiaotong University, Xi'an, Shaanxi, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cao</LastName>
                    <ForeName>Yong-Xiao</ForeName>
                    <Initials>YX</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yu</LastName>
                    <ForeName>Jun</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Shaanxi Key Laboratory of Ischemic Cardiovascular Disease, Xi'an Medical University, Xi'an, Shaanxi, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology, The Second Affiliated Hospital, Xi'an Medical University, Xi'an, Shaanxi, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Central Laboratory, Xi'an International Medical Center, Xi'an, Shaanxi, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>2018ZDXM-SF-068</GrantID>
                    <Agency>Fund of key problems of social development science and technology of Shaanxi Province</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2018ZDKF09</GrantID>
                    <Agency>Fund of Shaanxi key laboratory of ischemic cardiovascular disease</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>81670001</GrantID>
                    <Agency>National Natural Science Foundation of China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>81870172</GrantID>
                    <Agency>National Natural Science Foundation of China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>81470438</GrantID>
                    <Agency>National Natural Science Foundation of China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2018JQ8051</GrantID>
                    <Agency>Shaanxi Provincial science and technology department natural science basic research project</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Environ Toxicol</MedlineTA>
            <NlmUniqueID>100885357</NlmUniqueID>
            <ISSNLinking>1520-4081</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">5-HT2A receptor</Keyword>
            <Keyword MajorTopicYN="N">MAPK pathway</Keyword>
            <Keyword MajorTopicYN="N">fine particulate matter</Keyword>
            <Keyword MajorTopicYN="N">inflammatory mediator</Keyword>
            <Keyword MajorTopicYN="N">mesenteric artery</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31199065</ArticleId>
            <ArticleId IdType="doi">10.1002/tox.22810</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

